Neuropharmacology of AMPA and kainate receptors

Neuropharmacology

Volumn 37, Issue 10-11, 1998, Pages 1187-1204

  Bleakman, David ^a   Lodge, David ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 6,7,8,9 TETRAHYDRO 5 NITROBENZ[G]INDOLE 2,3 DIONE 3 OXIME; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; CYCLOTHIAZIDE; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; DOMOIC ACID; GLUTAMIC ACID; ION CHANNEL; KAINIC ACID; KAINIC ACID RECEPTOR; KAINIC ACID RECEPTOR ANTAGONIST; NEUROPROTECTIVE AGENT; QUISQUALIC ACID; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; COGNITIVE DEFECT; CONFERENCE PAPER; DEGENERATIVE DISEASE; EPILEPSY; NEUROPHARMACOLOGY; NEUROPROTECTION; NONHUMAN; PAIN; PRIORITY JOURNAL;

ANIMALS; COGNITION DISORDERS; EPILEPSY; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; NEURODEGENERATIVE DISEASES; PAIN; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID;

EID: 0032192550     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00139-7     Document Type: Conference Paper

References (252)

1. Agrawal, S.G., Evans, R.H., 1986. The primary afferent depolarizing action of kainate in the rat. Br. J. Pharmacol. 87, 345-355.
2. Arai, A., Kessler, M., Xiao, P., Ambros-Ingerson, J., Rogers, G., Lynch, G.A., 1994. A centrally active drug that modulates AMPA receptor gated currents. Brain Res. 638, 343-346.
3. Ault, B., Evans, R.H., Francis, A.A., Oakes, D.J., Watkins, J.C., 1980. Selective depression of excitatory amino acid-induced depolarizations by magnesium ions in isolated spinal cord preparations. J. Physiol. 307, 413-428.
4. Bahn, S., Volk, B., Wisden, W., 1994. Kainate receptor gene expression in the developing rat brain. J. Neurosci. 14, 5525-5547.
5. Barbour, B., Keller, B.U., Llano, I., Marty, A., 1994. Prolonged presence of glutamate during excitatory synaptic transmission to cerebellar Purkinje cells. Neuron 12, 1331-1343.
6. Bennett, J.A., Dingledine, R., 1995. Topology profile for a glutamate receptor: three transmembrane domains and a channel lining reentrant membrane loop. Neuron 14, 373-384.
7. Benveniste, H., Drejer, J., Schousboe, A., Diemer, N.H., 1984. Elevation of extracellular concentrations of glutamate and aspartate in the rat during transient cerebral ischaemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369-1374.
8. Bernard, A., Khrestchatisky, M., 1994. Assessing the extent of RNA editing in the TMII region of GluR5 and GluR6 kainate receptors during rat brain development. J. Neurochem. 62, 2057-2060.
9. Bernert, H., Turski, L., 1996. Traumatic brain damage prevented by the non-n-methyl-D-aspartate antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. Proc. Natl. Acad. Sci. USA 93, 5235-5240.
10. Bettler, B., Boulter, J., Hermans-Borgmeyer, L, O'Shea-Greenfield, A., Deneris, E.S., Moll, C., Borgmeyer, U., Hollmann, M., Heinemann, S., 1990. Cloning of a novel glutamate receptor subunit, GluR5: expression in the central nervous system during development. Neuron 5, 583-595.
11. Bettler, B., Egebjerg, J., Sharma, G., Pecht, G., Herman-Borgmeyer, I., Moll, C., Stevens, C.F., Heinemann, S., 1992. Cloning of a putative glutamate receptor: a low affinity kainate binding subunit. Neuron 8, 257-265.
12. Blaschke, M., Keller, B.U., Rivosecchi, R., Hollmann, M., Heinemann, S., Konnerth, A., 1993. A single amino acid determines the subunit-specific spider toxin block of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor channels. Proc. Natl. Acad. Sci. USA 90, 6528-6532.
13. Bleakman, D., Schoepp, D.D., Ballyk, B., Bufton, H., Sharpe, E.F., Thomas, K., Ornstein, P.L., Kamboj, R.K., 1996. Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S, 4aR, 6R, 8aR)-6-[2-(1 (2) H-tetrazole-5-yl ethyl] decahydroisoquinoline-3 carboxylic acid. Mol. Pharmacol. 49, 581-585.
14. Bliss, T.V.P., Collingridge, G.L., 1993. A synaptic model of memory: long term potentiation in the hippocampus. Nature 361, 31-39.
15. Bochet, P., Audinat, E., Lambolez, B., Crepel, F., Rossier, J., Iino, M., Tsuzuki, K., Ozawa, S., 1994. Subunit composition at the single-cell level explains functional properties of a glutamategated channel. Neuron 12, 383-388.
16. Boulter, J., Hollmann, M., O'Shea-Greenfield, A., Hartley, M., Deneris, E., Maron, C., Heinemann, S., 1990. Molecular cloning and functional expression of glutamate receptor subunit genes. Science 249, 1033-1037.
17. Bowie, D., Mayer, M.L., 1995. Inward rectification of both AMPA and kainate subtype glutamate receptors generated by polyamine-mediated ion channel block. Neuron 15, 453-462.
18. Bowie, D., Smart, T.G., 1991. Interaction of 5-bromowillardiine with non-NMDA receptors expressed in Xenopus laevis oocytes injected with chick brain mRNA. Neurosci. Lett. 121, 68-72.
19. Bowie, D., Smart, T.G., 1993. Thiocyanate ions selectively antagonize AMPA-evoked responses in Xenopus laevis oocytes microinjected with rat brain mRNA. Br. J. Pharmacol. 109, 779-787.
20. Brackley, P.T.H., Bell, D.R., Choi, S.K., Nakanishi, K., Usherwood, P.N.R., 1993. Selective antagonism of native and cloned kainate and NMDA receptors by polyamine-containing toxins. J. Pharmacol. Exp. Ther. 266, 1573-1580.
21. Bradford, H.F., 1995. Glutamate, GABA and epilepsy. Prog. Neurobiol. 47, 477-511.
22. Brauner-Osborne, H., Nielsen, B., Stensbol, T.B., Johansen, T.N., Skjaerbaek, N., Krogsgaard-Larsen, P., 1997. Molecular pharmacology of 4-substituted glutamic acid analogues at ionotropic and metabotropic excitatory amino acid receptors. Eur. J. Pharmacol. 335, R1-3.
23. Brorson, J.R., Bleakman, D., Chard, P.S., Miller, R.J., 1992. Calcium directly permeates kainate/AMPA receptors in cultures cerebellar Purkinje neurons. Mol. Pharmacol. 41, 603-608.
24. Buchan, A.M., Li, H., Cho, S., Pulsinelli, W.A., 1991. Blockade of AMPA receptor prevents CA1 hippocampal injury following severe transient forebrain ischemia in adult rats. Neurosci. Lett. 132, 255-258.
25. Bullock, R., Graham, D.I., Swanson, S., McCulloch, J., 1994. Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat. J. Cereb. Blood Flow Metab. 14, 466-471.
26. Burnashev, N., Schoepfer, R., Monyer, H., Ruppersberg, J.P., Gunther, W., Seeburg, P.H., Sakmann, B., 1992a. Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor. Science 257, 1415-1419.
27. Burnashev, N., Khordorova, A., Jonas, P., Helm, P.J., Wisden, Q., Monyer, H., Seeberg, P.H., Sakmann, B., 1992b. Calcium permeable AMPA/kainate receptors in fusiform cerebellar glial cells. Science 256, 1566-1570.
28. Burnashev, N., Villarroel, A., Sakmann, B., 1996. Dimensions and ion selectivity of recombinant AMPA and kainate receptor channels and their dependence on Q/R site residues. J. Physiol. 496, 165-173.
29. 3H]AMPA receptor binding in the rat hippocampal formation. Neurobiol. Learn. Mem. 64, 257-264.
30. 3H-AMPA binding following inhibitory avoidance training in the rat. Neurobiol. Learn. Mem. 66, 85-88.
31. Castillo, P.E., Malenka, R.C., Nicoll, R.A., 1997. Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons. Nature 388, 182-186.
32. Chapman, A.G., Smith, S.E., Meldrum, B.S., 1991. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI52466, in mice. Epilepsy Res. 9, 92-96.
33. Chapman, A.G., Al-Zubaidy, Z., Meldrum, B.S., 1993. Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice. Eur. J. Pharmacol. 231, 301-303.
34. Chen, G.Q., Gouaux, E., 1997. Overexpression of a glutamate receptor (GluR2) ligand binding domain in Escherichia coli: application of a novel protein folding screen. Proc. Natl. Acad. Sci. USA 94, 13431-13436.
35. Chimirri, A., De Sarro, G., De Sarro, A., Gitto, R., Grasso, S., Quartarone, S., Zappala, M., Giusti, P., Libri, V., Constanti, A., Chapman, A.G., 1997. 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists. J. Med. Chem. 40, 1258-1269.
36. Chittajallu, R., Vignes, M., Dev, K.K., Barnes, J.M., Collingridge, G.L., Henley, J.M., 1996. Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Nature 379, 78-81.
37. Choi, D.W., 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
38. Clarke, V.R.J., Ballyk, B.A., Hoo, K.H., Mandelzys, A., Pellizzari, A., Bath, C.P., Thomas, J., Sharpe, E.F., Davies, C.H., Ornstein, P.L., Schoepp, D.D., Kamboj, R.K., Collingridge, G.L., Lodge, D., Bleakman, D., 1997. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature 389, 599-603.
39. Collingridge, G.L., Lester, R.A.J., 1989. Excitatory amino acid receptors in the vertebrate nervous system. Pharmacol. Rev. 40, 143-210.
40. Couratier, P., Hugon, J., Sindou, P., Vallat, J.M., Dumas, M., 1993. Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors. Lancet 341, 265-268.
41. Curtis, D.R., Johnson, G.A.R., 1974. Amino acid transmitters in the mammalian central nervous system. Ergebnisse der Physiologie, Biologischen Chemie und Experimentellen Pharmakologie 69, 97-188.
42. Curtis, D.R., Phillis, J.W., Watkins, J.C., 1959. Chemical excitation of spinal neurons. Nature 183, 611-612.
43. Curtis, D.R., Duggan, A.W., Felix, D., Johnson, G.A.R., Tebecis, A.K., Watkins, J.C., 1972. Excitation of central mammalian central neurons by acidic amino acids. Brain Res. 41, 283-301.
44. Danysz, W., Zajaczkowski, W., Parsons, C.G., 1995. Modulation of learning processes by ionotropic glutamate receptor ligands. Behav. Pharmacol. 6, 455-474.
45. Davies, J., Watkins, J.C., 1979. Selective antagonism of amino acid-induced and synaptic events in the cat spinal cord. J. Physiol. 297, 621-635.
46. Davies, J., Watkins, J.C., 1985. Depressant actions of γ-D-glutamyl aminomethyl sulphonate (GAMS) on amino acid-induced and synaptic excitation in the cat spinal cord. Brain Res. 327, 113-120.
47. Davis, C.M., Moskovitz, B., Nguyen, M.A., Tran, B.B., Arai, A., Lynch, G., Granger, R., 1997. A profile of behavioral changes produced by facilitation of AMPA-type glutamate receptors. Psychopharmacology 133, 161-167.
48. Debonnel, G., Weiss, M., de Montigny, C., 1989. Reduced neuroexcitatory effect of domoic acid following mossy fiber denervation of the rat dorsal hippocampus: further evidence that toxicity of domoic acid involves kainate receptor activation. Can. J. Physiol. Pharmacol. 67, 904-908.
49. Desos, P., Serkiz, B., Morain, P., Lepagnol, J., Cordi, A., 1996. Enantioselective synthesis of a pyrolo-benzothiadiazide derivative S18986, a new AMPA receptor positive modulator. Bioorg. Med. Chem. Lett. 6, 3003-3008.
50. Doble, A., 1995. Excitatory amino acid receptors and neurodegeneration. Therapie 50, 319-337.
51. Donevan, S.D., Rogawski, M.A., 1993. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 10, 51-59.
52. Donevan, S.D., Yamaguchi, S., Rogawski, M.A., 1994. Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity. J. Pharmacol. Exp. Ther. 271, 25-29.
53. Dray, A., Urban, L., Dickenson, A., 1994. Pharmacology of chronic pain. Trends Pharmacol. Sci. 15, 190-197.
54. Durmuller, N., Craggs, M., Meldrum, B.S., 1994. The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures. Epilepsy Res. 17, 167-174.
55. 2+ permeability of unedited and edited versions of the kainate selective glutamate receptor GluR6. Proc. Natl. Acad. Sci. USA 90, 755-759.
56. Egebjerg, J., Bettler, B., Hermans-Borgmeyer, I., Heinemann, S., 1991. Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA. Nature 351, 745-748.
57. 2+ like selective antagonism of excitatory amino acid-induced responses by α, ε-diaminopimelic acid, D-α-aminoadipate and HA-966 in isolated spinal cord of frog and immature rat. Brain Res. 148, 536-542.
58. Everts, I., Villmann, C., Hollmann, M., 1997. N-glycosylation is not a prerequisite for glutamate receptor function but is essential for lectin modulation. Mol. Pharmacol. 52, 861-873.
59. Ferrèr-Montiel, A.V., Montal, M., 1996. Pentameric subunit stoichiometry of a neuronal glutamate receptor. Proc. Natl. Acad. Sci. USA 93, 2741-2744.
60. Festoff, B.W., 1996. Amyotrophic lateral sclerosis: current and future treatment strategies. Drugs 51, 28-44.
61. Fisher, R.S., Alger, B.E., 1984. Electrophysiological mechanisms of kainic acid-induced epileptiform activity in the rat hippocampal slice. J. Neurosci. 4, 1312-1323.
62. Fletcher, E.J., Lodge, D., 1996. New developments in the molecular pharmacology of AMPA and kainate receptors. Pharmacol. Ther. 70, 65-89.
63. Fletcher, E.J., Martin, D., Aram, J.A., Lodge, D., Honoré, T., 1988. Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cord in vitro. Br. J. Pharmacol. 95, 585-597.
64. Foster, A.C., Fagg, G.E., 1984. Acidic amino acid binding sites in mammalian neuronal membranes: their characteristics and relationship to synaptic receptors. Brain Res. Rev. 7, 103-164.
65. Gaiarsa, J.L., Zagrean, L., Ben-Ari, Y., 1994. Neonatal irradiation prevents the formation of hippocampal mossy fibers and the epileptic action of kainate on rat CA3 pyramidal neurons. J. Neurophysiol. 71, 204-215.
66. Gannon, R.L., Terrian, D.M., 1991. Presynaptic modulation of glutamate and dynorphin release by excitatory amino acids in the guinea-pig hippocampus. Neuroscience 41, 401-410.
67. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 15, 193-204.
68. Gilbertson, T.A., Scobey, R., Wilson, M., 1991. Permeation of calcium ions through non-NMDA glutamate channels in retinal bipolar cells. Science 251, 1613-1615.
69. Gill, R., 1994. The pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia. Cereb. Brain Metab. Rev. 6, 225-256.
70. Gill, R., Lodge, D., 1995. The neuroprotective effects of the decahydroisoquinoline, LY215490, a novel AMPA antagonist in focal ischaemia. Neuropharmacology 33, 1529-1536.
71. Gill, R., Nordholm, L., Lodge, D., 1992. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model. Brain Res. 580, 35-43.
72. Graham, S.H., Chen, J., Lan, J.Q., Simon, R.P., 1996. A dose-response study of neuroprotection using the AMPA antagonist, NBQX, in rat focal ischemia. J. Pharmacol. Exp. Ther. 276, 1-4.
73. Granger, R., Deadwyler, S., Davis, M., Moskovitz, B., Kessler, M., Rogers, G., Lynch, G., 1996. Facilitation of glutamate receptors reverses an age-associated memory impairment in rats. Synapse 22, 332-337.
74. Gu, Z.-Q., Hesson, D., Pelletier, J., Maccechini, M.-L., Zhou, L.-M., Skolnick, P., 1995. Synthesis, resolution, and biological evaluation of the four stereoisomers of 4-methylglutamic acid: selective probes of kainate receptors. J. Med. Chem. 38, 2518-2520.
75. Hampson, D.R., Huie, D., Wenthold, R.J., 1987. Solubilization of kainic acid binding sites from rat brain. J. Neurochem. 49, 1209-1215.
76. Hampson, R.E., Rogers, G., Lynch, G., Deadwyler, S.A., 1998a. Facilitative effects of the ampakine CX516 on short-term memory in rats: correlations with hippocampal neuronal activity. J. Neurosci. 18, 2748-2763.
77. Hampson, R.E., Rogers, G., Lynch, G., Deadwyler, S.A., 1998b. Facilitative effects of the ampakine CX516 on short-term memory in rats: enhancement of delayed-nonmatch-to-sample performance. J. Neurosci. 18, 2740-2747.
78. Hansen, J.J., Flemming, J.S., Lund, T.M., Nielsen, B., Reinhardt, A., Breum, I., Krogsgaard-Larsen, P., 1995. AMPA receptor agonists: structural conformational and stereochemical aspects. In: Krogsgaard-Larsen, P., Hansen, J.J. (Eds.), Excitatory Amino Acid Receptors: Design of Agonists and Antagonists. Ellis Horwood, Chichester, UK.
79. 3H]AMPA to rat brain synaptic membranes: effects of a series of structural analogues of the non-NMDA receptor agonist, willardiine. Neuropharmacology 34, 405-410.
80. Hayashi, T., 1952. A physiological study of the epileptic seizures following cortical stimulation in animals and its application to human clinics. Jpn. J. Physiol. 3, 46-64.
81. Hayashi, T., 1954. Effects of sodium glutamate on the nervous system. Keio J. Med. 3, 183-192.
82. Herb, A., Burnashev, N., Werner, P., Sakmann, B., Wisden, W., Seeburg, P.H., 1992. The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits. Neuron 8, 775-785.
83. Herlitze, S., Raditsch, M., Ruppersberg, J.P., Jahn, W., Monyer, H., Schoepfer, R., Witzemann, V., 1993. Argiotoxin detects molecular differences in AMPA receptor channels. Neuron 10, 1131-1140.
84. Hestrin, S., 1992. Activation and desensitization of glutamate-activated channels mediating fast excitatory synaptic currents in the visual cortex. Neuron 9, 991-999.
85. Hollmann, M., Heinemann, S., 1994. Cloned glutamate receptors. Annu. Rev. Neurosci. 17, 31-108.
86. Hollmann, M., O'Shea-Greenfield, A., Rogers, S.W., Heinemann, S., 1989. Cloning and functional expression of a member of the glutamate receptor family. Nature 342, 643-648.
87. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252, 851-853.
88. Honoré, T., Drejer, J., 1988. Chaotropic agents affect the conformation of quisqualate receptors in rat cortical membranes. J. Neurochem. 51, 457-461.
89. Honoré, T., Davies, S.N., Drejer, J., Fletcher, E.J., Jacobsen, P., Lodge, D., Nielsen, F.E., 1988. Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science 241, 701-703.
90. 3H-CNOX binds with equal affinity to two agonist states of quisqualate receptors. Biochem. Pharmacol. 38, 3207-3212.
91. Hosli, L., Andres, P.F., Hosli, E., 1973. Ionic mechanisms underlying the depolarization of L-glutamate on rat and human spinal neurons in tissue culture. Experientia 29, 1244-1247.
92. Huettner, J.E., 1990. Glutamate receptor channels in rat DRG neurons: activation by kainate and quisqualate and blockade of desensitization by Con A. Neuron 5, 255-266.
93. Hume, R.I., Dingledine, R., Heinemann, S.F., 1991. Identification of a site in glutamate receptor subunits that controls calcium permeability. Science 253, 1028-1030.
94. Huntley, G.W., Rogers, S.W., Moran, T., Janssen, W., Archin, N., Vickers, J.C., Cauley, K., Heinemann, S.F., Morrison, J.H., 1993. Selective distribution of kainate receptor subunit immunoreactivity in monkey neocortex revealed by a monoclonal antibody that recognizes glutamate receptor subunits GluR5/6/7. J. Neurosci. 13, 2965-2981.
95. Iino, M., Ozawa, S., Tsuzuki, K., 1990. Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurons. J. Physiol. 424, 151-165.
96. 2+ permeable AMPA receptors by joro spider toxin in cultured rat hippocampal neurones. J. Physiol. 496, 431-437.
97. Ingvar, M., Ambros-Ingerson, J., Davis, M., Granger, R., Kessler, M., Rogers, G.A., Schehr, R.S., Lynch, G., 1997. Enhancement by an ampakine of memory encoding in humans. Exp. Neurol. 146, 553-559.
98. Isaacson, J.S., Nicoll, R.A., 1991. Aniracetam reduces glutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus. Proc. Natl. Acad. Sci. USA 88, 10936-10940.
99. Ito, I., Tanabe, S., Kohda, A., Sugiyama, H., 1990. Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J. Physiol. 424, 533-543.
100. Izquierdo, I., Medina, J.H., 1995. Correlation between the pharmacology of long-term potentiation and the pharmacology of memory. Neurobiol. Learn. Mem. 63, 19-32.
101. Jane, D.E., Hoo, K., Kamboj, R., Deverill, M., Bleakman, D., Mandelzys, A., 1997. Synthesis of willardiine and 6-azawillardiine analogs: Pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes. J. Med. Chem. 40, 3645-3650.
102. Johansen, T.H., Chaudhary, A., Verdoorn, T.A., 1995. Interactions among GYKI 52466, cyclothiazide and aniracetam at recombinant AMPA and kainate receptors. Mol. Pharmacol. 48, 946-955.
103. Jonas, P., Burnashev, N., 1995. Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels. Neuron 15, 987-990.
104. 2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression. Neuron 12, 1281-1289.
105. Jones, K.A., Wilding, T.J., Huettner, J.E., Costa, A.-M., 1997. Desensitization of Kainate receptors by kainate, glutamate, and diastereomers of 4-methylglutamate. Neuropharmacology 36, 853-863.
106. Jones, M.G., Lodge, D., 1991. Comparison of some arthropod toxins and toxin fragments as antagonists of excitatory amino acid induced excitation of rat spinal neurons. Eur. J. Pharmacol. 204, 203-209.
107. Judge, M.E., Sheardown, M.J., Jacobsen, P., Honoré, T., 1991. Protection against post-ischemic behavioral pathology by the α-amino-3-hydroxy-5-methyl-4-isoaxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) in the gerbil. Neurosci. Lett. 133, 291-294.
108. Kamboj, R.K., Schoepp, D.D., Nutt, S., Shekter, L., Korczak, B., True, R.A., Rampersad, V., Zimmerman, D.M., Wosnick, M.A., 1994. Molecular cloning, expression and pharmacological characterization of human EAA1, a human kainate receptor. J. Neurochem. 62, 1-9.
109. Kamboj, S.K., Swanson, G.T., Cull-Candy, S.G., 1995. Intracellular spermine confers rectification on rat calcium-permeable AMPA and kainate receptors. J. Physiol. 486, 297-303.
110. Kawasaki-Yatsugi, S.-I., Yatsugi, S., Koshiya, K., Shimizu-Sasamata, M., 1997. Neuroprotective effect of YM90K, an AMPA receptor antagonist, against delayed neuronal death induced by transient global ischemia in gerbils and rats. Jpn. J. Pharmacol. 74, 253-260.
111. Kehl, S.J., McLennan, H., Collingridge, G.L., 1984. Effects of folic and kainic acids on synaptic responses of hippocampal neurones. Neuroscience 11, 111-124.
112. Keinänen, K., Wisden, W., Sommer, B., Werner, P., Herb, A., Verdoorn, T.A., Sakmann, B., Seeburg, P.H., 1990. A family of AMPA-selective glutamate receptors. Science 249, 556-560.
113. Keinänen, K., Arvola, M., Kuusinen, A., Johnson, M., 1997. Ligand recognition in glutamate receptors: insights from mutagenesis of the soluble alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-binding domain of glutamate receptor type D (GluR-D). Biochem. Soc. Trans. 25, 835-838.
114. Keller, B.U., Blashke, M., Rivosecchi, R., Hollmann, M., Heinemann, S.F., Konnerth, A., 1993. Identification of a subunit specific antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazole-propionate/kainate receptor channels. Proc. Natl. Acad. Sci. USA 90, 605-609.
115. Kim, M., Campeau, S., Falls, W.A., Davis, M., 1993. Infusion of non-NMDA receptor antagonist CNQX into the amygdala blocks the expression of fear-potentiated conditioned startle. Behav. Neural Biol. 59, 5-8.
116. Kiskin, N.I., Krishtal, O.A., Tsyndrenko, A.Y., 1986. Excitatory amino acid receptors in hippocampal neurons. Kainate fails to desensitize them. Neurosci. Lett. 63, 225-230.
117. Köhler, M., Burnashev, N., Sakmann, B., Seeberg, P.H., 1993. Determinants of calcium permeability in both TM1 and TMII of high affinity kainate receptor channels: diversity by RNA editing. Neuron 10, 491-500.
118. Kristian, T., Siesjo, B.K., 1998. Calcium in ischemic cell death. Stroke 29, 705-718.
119. Krogsgaard-Larsen, P., Honoré, T., Hansen, J.J., Curtis, D.R., Lodge, D., 1980. New class of glutamate agonist structurally related to ibotenic acid. Nature 284, 64-66.
120. Krogsgaard-Larsen, P., Madsen, U., Ebert, B., Hansen, J.J., 1994. In: Krogsgaard-Larsen, P., Hansen, J.J. (Eds.), Excitatory Amino Acid Receptors: Design of Agonists and Antagonists. Ellis Horwood, Chichester, UK, pp. 34-55.
121. Lambolez, B., Audinat, E., Bochet, P., Crepel, F., Rossier, J., 1992. AMPA receptor subunits expressed by single Purkinje cells. Neuron 9, 247-258.
122. Larson, J., Lieu, T., Petchpradub, V., LeDuc, B., Ngo, H., Rogers, G.A., Lynch, G., 1995. Facilitation of olfactory learning by a modulator of AMPA receptors. J. Neurosci. 15, 8023-8030.
123. Lauridsen, J., Honoré, T., Krogsgaard-Larsen, P., 1985. Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors. J. Med. Chem. 28, 668-672.
124. Le Peillet, E., Arvin, B., Moncada, C., Meldrum, B.S., 1992. The non-NMDA antagonists, NBQX and GYKI52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat. Brain Res. 571, 115-120.
125. Lerma, J., 1997. Kainate reveals its targets. Neuron 19, 1155-1158.
126. Lerma, J., Paternain, A.V., Naranjo, J.R., Mellström, B., 1993. Functional kainate-selective glutamate receptors in cultured hippocampal neurons. Proc. Natl. Acad. Sci. USA 90, 11688-11692.
127. Lerma, J., Morales, M., Vicente, M.A., Herreras, O., 1997. Glutamate receptors of the kainate type and synaptic transmission. Trends Neurosci. 20, 9-12.
128. Li, H., Buchan, A.M., 1993. Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury. J. Cereb. Blood Flow Metab. 13, 933-939.
129. Lipton, S.A., Rosenberg, P.A., 1994. Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. 330, 613-622.
130. Lodge, D., Bond, A., O'Neill, M.J., Hicks, C.A., Jones, M.G., 1996. Stereoselective effects of 2,3-benzodiazepines in vivo: electrophysiology and neuroprotection studies. Neuropharmacology 35, 1681-1688.
131. Lomeli, H., Wisden, W., Köhler, M., Keinänen, K., Sommer, B., Seeburg, P.H., 1992. High-affinity kainate and domoate receptors in rat brain. FEBS Lett. 307, 139-143.
132. Lomeli, H., Mosbacher, J., Melcher, T., Hoger, T., Geiger, J.R.P., Kuner, T., Monyer, H., Higuchi, M., Bach, A., Seeburg, P.H., 1994. Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science 266, 1709-1713.
133. 3H]kainic acid to receptor sites in the rat brain. Mol. Pharmacol. 15, 492-505.
134. Madsen, U., Ebert, B., Krogsgaard-Larsen, P., 1994. Modulation of AMPA receptor function in relation to glutamatergic abnormalities in Alzheimer's disease. Biomed. Pharmacother. 48, 305-311.
135. Malva, J.O., Carvalho, A.P., Carvalho, C.M., 1998. Kainate receptors in hippocampal CA3 subregion: evidence for a role in regulating neurotransmitter release. Neurochem. Int. 32, 1-6.
136. Mano, I., Teichberg, V.I., 1998. A tetrameric subunit stoichiometry for a glutamate receptor channel complex. Neuroreport 9, 327-331.
137. Mayer, M.L., Vyklicky, L. Jr., 1989. Concanavalin A selectively reduces desensitization of mammalian neuronal quisqualate receptors. Proc. Natl. Acad. Sci. USA 86, 1411-1415.
138. McKernan, M.G., Shinnick-Gallagher, P., 1997. Fear conditioning induces a lasting potentiation of synaptic currents in vitro. Nature 390, 607-611.
139. McLennan, H., 1983. Receptors for excitatory amino acids in the mammalian central nervous system. Prog. Neurobiol. 20, 251-271.
140. McLennan, H., Lodge, D., 1979. The antagonism of amino acid-induced excitation of spinal neurones in the cat. Brain Res. 169, 8390.
141. Meldrum, B., Garthwaite, J., 1990. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11, 379-385.
142. Molnär, E., Baude, A., Richmond, S.A., Patel, P.B., Somogyi, P., McIlhinney, R.A.J., 1993. Biochemical and immunocytochemical characterization of antipeptide antibodies to a cloned GluR1 glutamate receptor subunit: cellular and subcellular distribution in the rat forebrain. Neuroscience 53, 307-326.
143. 3H]kainic acid binding sites in rat CNS as determined by autoradiography. Brain Res. 252, 91-100.
144. 3H]AMPA binding sites in rat brain as determined by quantitative autoradiography. Brain Res. 324, 160-164.
145. Monyer, H., Seeburg, P.H., Wisden, W., 1991. Glutamate operated channels: Developmentally early and mature forms arise by alternative splicing. Neuron 6, 799-810.
146. Mulle, C., Sailer, A., Peréz-Otaño, I., Dickenson-Anson, H., Castillo, P.E., Bureau, I., Maron, C., Gage, F.H., Mann, J.R., Bettler, B., Heinemann, S.F., 1998. Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature 392, 601-605.
147. Nakanishi, N., Shneider, N.A., Axel, R., 1990. A family of glutamate receptor genes: evidence for the formation of heteromultimeric receptors with distinct channel properties. Neuron 5, 569-581.
148. Nicoletti, F., Meek, J.L., Iadarola, M.J., Chuange, D.M., Roth, B.L., Costa, E., 1986. Coupling of inositol phospholipid metabolism with excitatory amino acid recognition sites in rat hippocampus. J. Neurochem. 46, 40-46.
149. Nusser, Z., Mulvihill, E., Streit, P., Somogyi, P., 1994. Subsynaptic segregation of metabotropic and ionotropic glutamate receptors as revealed by immunogold localization. Neuroscience 61, 421-427.
150. Obrenovitch, T.P., Urenjak, J., 1997. Altered glutamatergic transmission in neurological disorders: From high extracellular glutamate to excessive synaptic efficacy. Prog. Neurobiol. 51, 39-87.
151. Ohmori, J., Sakamoto, S., Kubota, H., Shimizu-Sasamata, M., Okada, M., Kawasaki, S., Hidaka, K., Togami, J., Furuya, T., Murase, K., 1994. 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: structure-activity relationships for the AMPA-type non-NMDA receptor. J. Med. Chem. 37, 467-475.
152. O'Neill, M.J., Bond, A., Ornstein, P.L., Ward, M.A., Hicks, C.A., Hoo, K., Bleakman, D., Lodge, D., 1998. Decahydroisoquinolines: novel competitive AMPA/KA antagonists with neuroprotective effects in global cerebral ischemia. Neuropharmacology 37, 1211-1222.
153. Ornstein, P.L., Arnold, M.B., Augenstein, N.K., Lodge, D., Leander, J.D., Schoepp, D.D., 1993. (3SR,4aRS,6RS, 8aRS)-6-[2-(1H-tetrazol-5-yl)ethyl]-decahydroisoquinoline-3-carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist. J. Med. Chem 36, 2046-2048.
154. Palmer, A.J., Lodge, D., 1993. Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655. Eur. J. Pharmacol. 244, 193-194.
155. Partin, K.M., Patneau, D.K., Winters, C.A., Mayer, M.L., Buonanno, A., 1993. Selective modulation of desensitization at AMPA receptors vs kainate receptors by cyclothiazide and concanavalin A. Neuron 11, 1069-1082.
156. Partin, K.M., Fleck, M.W., Mayer, M.L., 1996. AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam and thiocyanate. J. Neurosci. 16, 6634-6647.
157. Paternain, A.V., Morales, M., Lerma, J., 1995. Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons. Neuron 14, 185-189.
158. Patneau, D.K., Mayer, M.L., 1990. Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J. Neurosci. 10, 2385-2399.
159. Patneau, D.K., Vyklicky, L. Jr., Mayer, M.L., 1993. Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate. J. Neurosci. 13, 3496-3509.
160. Pelletier, J.C., Hesson, D.P., Jones, K.A., Costa, A.-M., 1996. Substituted 1,2-dihydro-phthamalazines: Potent, selective and noncompetitive inhibitors of AMPA receptors. J. Med. Chem. 39, 343-346.
161. Petralia, R.S., Wenthold, R.J., 1992. Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain. J. Comp. Neurol. 318, 329-354.
162. Pin, J.-P., Duvoisin, R., 1995. Review: Neurotransmitter receptors I: The metabotropic glutamate receptors: Structure and functions. Neuropharmacology 34, 1-26.
163. Plaitakis, A., 1990. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis. Ann. Neurol. 28, 3-8.
164. Price, C.J., Raymond, L.A., 1996. Evans blue antagonizes both alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate and kainate receptors and modulates receptor desensitization. Mol. Pharmacol. 50, 1665-1671.
165. Priestley, T., Woodruff, G.N., Kemp, J.A., 1989. Antagonism of responses to excitatory amino acids on rat cortical neurones by the spider toxin, argiotoxin636. Br. J. Pharmacol. 97, 1315-1323.
166. Procter, M.J., Houghton, A.K., Faber, E.S.L., Ornstein, P.L., Lodge, D., Headley, P.M. (1998) Actions of kainate and AMPA selective glutamate receptor ligands on nociceptive processing in the spinal cord. Neuropharmacology, 37, 1287-1297.
167. Quillfeldt, J.A., Schmitz, P.K., Walz, R., Bianchin, M., Zanatta, M.S., Medina, J.H., Izquierdo, I., 1994. CNQX infused into enthorinal cortex blocks memory expression and AMPA reverses the effect. Pharmacol. Biochem. Behav. 48, 437-440.
168. Rammes, G., Swandulla, D., Collingridge, G.L., Hartmann, S., Parsons, C.G., 1996. Interactions of 2,3 benzodiazepines and cyclothiazide at AMPA receptors: patch clamp recordings in cultured neurons and area CA1 in hippocampal slices. Br. J. Pharmacol. 117, 1209-1221.
169. Represa, A., Tremblay, E., Ben-Ari, Y., 1987. Kainate binding sites in the hippocampal mossy fibres: localization and plasticity. Neuroscience 20, 739-748.
170. Robinson, J.H., Deadwyler, S.A., 1981. Kainic acid produces depolarization of CA3 pyramidal cells in the vitro hippocampal slice. Brain Res. 221, 117-127.
171. Rodriguez-Moréno, A., Herreras, O., Lerma, J., 1997. Kainate receptors presynaptically down regulate GABAergic inhibition in the rat hippocampus. Neuron 19, 893-901.
172. Rogan, M.T., Staubli, U.V., LeDoux, J.E., 1997. Fear conditioning induces associative long-term potentiation in the amygdala. Nature 390, 604-607.
173. Rogawski, M.A., 1993. Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci. 14, 325-331.
174. Rosemund, C., Stern-Bach, Y., Stevens, C., 1998. The tetrameric structure of a glutamate receptor channel. Science 280, 1596-1599.
175. Rothman, S.M., Olney, J.W., 1987. Excitotoxicity and the NMDA receptor. Trends Neurosci. 10, 299-302.
176. Rothstein, J.D., Tsai, G., Kuncl, R.W., Clawson, L., Cornblath, D.R., Drachman, D.B., Pestronk, A., Staunch, B.L., Coyle, J.T., 1990. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 28, 18-25.
177. Rothstein, J.D., Martin, L.J., Kuncl, R.W., 1992. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. New Engl. J. Med. 326, 1464-1468.
178. Rothstein, J.D., Jin, L., Dykes-Holberg, M., Kuncl, R.W., 1993. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA 90, 6591-6595.
179. Rothstein, J.D., Dykes-Hoberg, M., Pardo, C.A., Bristol, L.A., Jin, L., Kuncl, R.W., Kanai, Y., Hediger, M.A., Wang, Y., Schiekle, J.P., Welty, D.F., 1996. Knockout of glial transporters reveals a major role of astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675-686.
180. Ruano, D., Lambolez, B., Rossier, J., Paternain, A.V., Lerma, J., 1995. Kainate receptor subunits expressed in single cultured hippocampal neurons: molecular and functional variants by RNA editing. Neuron 14, 1009-1017.
181. Sahara, Y., Noro, N., Iida, Y., Soma, K., Nakamura, Y., 1997. Glutamate receptor subunits GluR5 and KA-2 are co-expressed in rat trigeminal ganglion neurons. J. Neurosci. 17, 6611-6620.
182. Sakimura, K., Morita, T., Kushiya, E., Mishina, M., 1992. Primary structure and expression of the γ2 subunit of the glutamate receptor channel selective for kainate. Neuron 8, 267-274.
183. Sang, C.N., Hostetter, M.P., Gracely, R.H., Chappell, A., Schoepp, D.D., Lee, G., Whitcup, S., Caruso, R., Max, M.B., 1998. Effects of AMPA/kainate antagonists in humans: reduction of hyperalgesia at subsedative doses. Anesthesiology, in press.
184. Savidge, J.R., Bleakman, D., Bristow, D.R., 1997. Identification of kainate receptor-mediated intracellular calcium increases in cultured rat cerebellar granule cells. J. Neurochem. 69, 1763-1766.
185. Schiffer, H.H., Swanson, G.T., Heinemann, S.F., 1997. Rat GluR7 and carboxy-terminus splice variant, GluR7b, are functional kainate receptor subunits with low sensitivity to glutamate. Neuron 19, 1141-1146.
186. Schneggenburger, R., Zhou, Z., Konnerth, A., Neher, E., 1993. Fractional contribution of calcium to the cation current through glutamate receptor channels. Neuron 11, 133-143.
187. Schoepp, D.D., Conn, P.J., 1993. Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol. Sci. 14, 13-20.
188. Schoepp, D.D., Lodge, D., Bleakman, D., Leander, J.D., Tizzano, J.P., Wright, R.A., Palmer, A.J., Salhoff, C.R., Ornstein, P.L., 1995. In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acid. Neuropharmacology 34, 1159-1168.
189. Sekiguchi, M., Fleck, M.W., Mayer, M.L., Takeo, J., Chiba, Y., Yamashita, S., Wad, K., 1997. A novel allosteric potentiator of AMPA receptors: 4-[2-(Phenylsulfonylamino)ethylthio]-2,6-difluoro-phenoxyacetamide. J. Neurosci. 17, 5760-5771.
190. Sekiguchi, M., Takeo, J., Harada, T., Morimoto, T., Kudo, Y., Yamashita, S., Kohsaka, S., Wada, K., 1998. Pharmacological detection of AMPA receptor heterogeneity by use of two allosteric potentiators in rat hippocampal cultures. Br. J. Pharmacol. 123, 1294-1303.
191. Shaw, P.J., 1992. Excitatory amino acid neurotransmission, excitotoxicity and excitotoxins. Curr. Opin. Neurol. Neurosurg. 5, 383-390.
192. Sheardown, M.J., Nielsen, E.O., Hansen, A.J., Jacobsen, P., Honoré, T., 1990. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuro-protectant for cerebral ischemia. Science 247, 571-574.
193. Sheardown, M.J., Suzdak, P.D., Nordholm, L., 1993. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Eur. J. Pharmacol. 236, 347-353.
194. Simmons, R.M., Li, D.L., Deverill, M., Ornstein, P.L., Iyengar, S., 1998. Kainate GluR5 receptor subtype mediates the nociceptive response to formulain in the rat. Neuropharmacology 37, 25-36.
195. Sladeczek, F., Pin, J.-P., Recasens, M., Bockaert, J., Weiss, S., 1985. Glutamate stimulates inositol phosphate formation in striatal neurons. Nature 317, 717-719.
196. Sloviter, R.S., Damiano, B.P., 1981. On the relationship between kainic acid-induced epileptiform activity and hippocampal neuronal damage. Neuropharmacology 20, 1003-1011.
197. Small, B.C., Baker, S.R., Rubio, A., Ballyk, B.A., Hoo, K.E., Mandelzys, A., Kamboj, R., Lodge, D., Bleakman, D., 1997. LY339434, a GluR5 selective kainate receptor agonist. Br. J. Pharmacol. 122, P59.
198. Small, B., Thomas, J., Kemp, M., Hoo, K., Ballyk, B., Deverill, M., Odgen, A., Rubio, A., Pedregal, C., Bleakman, D. (1998) LY339434, a GluR5 kainate receptor agonist. Neuropharmacology 37, 1261-1267.
199. Smith, S.E., Meldrum, B.S., 1992. Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI52466, after focal ischaemia in the rat. Stroke 23, 861-864.
200. Smith, S.E., Durmuller, N., Meldrum, B.S., 1991. The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Eur. J. Pharmacol. 201, 179-183.
201. Sommer, B., Keinänen, K., Verdoorn, T.A., Wisden, W., Burnashev, N., Herb, A., Köhler, M., Takagi, T., Sakmann, B., Seeburg, P.H., 1990. Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 249, 1580-1585.
202. Sommer, B., Köhler, M., Sprengel, R., Seeburg, P.H., 1991. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67, 11-19.
203. Sommer, B., Burnashev, N., Verdoorn, T.A., Keinänen, K., Sakmann, B., Seeburg, P.H., 1992a. A glutamate receptor channel with high affinity for domoate and kainate. EMBO J. 11, 1651-1656.
204. Sommer, B., Köhler, M., Sprengel, R., Seeburg, P.H., 1992b. RNA editing in brain controls a determinant of ion flow in glutamate gated channels. Cell 67, 11-19.
205. Spencer, P.S., Roy, D.N., Ludolph, A., Dwivedi, M.P., Schaumberg, H.H., 1986. Lathyrism: evidence for the role of the neuroexcitatory amino acid, BOAA. Lancet 2, 1066-1067.
206. Staubli, U., Perez, Y., Xu, F.B., Rogers, G., Ingvar, M., Stone-Elander, S., Lynch, G., 1994a. Centrally active modulators of glutamate receptors facilitate the induction of LTP in vivo. Proc. Natl. Acad. Sci. USA 91, 11158-11162.
207. Staubli, U., Rogers, G., Lynch, G., 1994b. Facilitation of glutamate receptors enhances memory. Proc. Natl. Acad. Sci. USA 91, 777-781.
208. Steele, R.J., Stewart, M.G., 1995. Involvement of AMPA receptors in maintenance of memory for a passive avoidance task in day-old domestic chicks (Gallus domesticus). Eur. J. Neurosci. 7, 1297-1304.
209. Stein, E., Cok, J.A., Seeberg, P.H., Verdoorn, T.A., 1992. Complex pharmacological properties of recombinant AMPA receptors subtypes. Mol. Pharmacol. 42, 864-871.
210. Stern-Bach, Y., Bettler, B., Hartley, M., Sheppard, P.O., O'Hara, P.J., Heinemann, S.F., 1994. Agonist selectivity of glutamate receptors is specified by two domains structurally related to bacterial amino acid binding proteins. Neuron 13, 1345-1357.
211. Stevens, C.F., 1998. A million dollar question: Does LTP = Memory? Neuron 20, 1-2.
212. Sugiyama, H., Watanabe, M., Taji, H., Yamamoto, Y., Ito, I., 1989. Pharmacological properties of quisqualate-and kainate-preferring glutamate receptors induced in Xenopus oocytes by rat and chick brain mRNA. Neurosci. Res. 7, 164-167.
213. Swanson, G.T., Feldmeyer, D., Kaneda, M., Cull-Candy, S.G., 1996. Effect of RNA editing and subunit co-assembly on single-channel properties of recombinant kainate receptors. J. Physiol. 492, 129-142.
214. Swanson, G.T., Kamboj, S.K., Cull-Candy, S.G., 1997. Single-channel properties of recombinant AMPA receptors depend on RNA editing, splice variation, and subunit composition. J. Neurosci. 17, 58-69.
215. Tang, C.M., Shi, Q.Y., Katchman, A., Lynch, G., 1991. Modulation of the timecourse of fast EPSPs and glutamate channel kinetics by aniracetam. Science 254, 288-290.
216. Tarnawa, I., Farkas, S., Berzsenyi, P., Pataki, A., Andrasi, F., 1989. Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466. Eur. J. Pharmacol. 167, 193-199.
217. Thompson, D.M., Guidotti, A., DiBella, M., Costa, E., 1995. 7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys. Proc. Natl. Acad. Sci. USA 92, 7667-7671.
218. Tocco, G., Devgan, K.K., Hauge, S.A., Weiss, C., Baudry, M., Thompson, R.F., 1991. Classical conditioning selectively increases AMPA receptor binding in rabbit hippocampus. Brain Res. 559, 331-336.
219. Tocco, G., Annala, A.J., Baudry, M., Thompson, R.F., 1992. Learning of a hippocampal-dependent conditioning task changes the binding properties of AMPA receptors in rabbit hippocampus. Behav. Neural Biol. 58, 222-231.
220. 3H]-(2S,4R)-4-methylglutamate: Pharmacological characterization in rabbit brain membranes. Neuropharmacology 36, 1483-1488.
221. Tsuzuki, K., Takeuchi, T., Ozawa, S., 1992. Agonist and subunit dependent potentiation of glutamate receptors by a nootropic drug aniracetam. Mol. Brain Res. 16, 105-110.
222. Tygesen, C.K., Jorgensen, M., Andersen, P.H., 1995. The importance of two specific domains in ligand binding to the AMPA/kainate glutamate receptors GluR2 and GluR6. FEBS Lett. 363, 184-188.
223. Verdoorn, T.A., Burnashev, N., Monyer, H., Seeberg, P.H., Sakmann, B., 1991. Structural determinants of ion flow through recombinant glutamate receptor channels. Science 252, 1715-1718.
224. Verdoorn, T.A., Johansen, T.H., Drejer, J., Nielsen, E.O., 1994. Selective block of recombinant GluR6 receptors by NS-102, a novel non-NMDA receptor antagonist. Eur. J. Pharmacol. 269, 43-49.
225. Vignes, M., Collingridge, G.L., 1997. The synaptic activation of kainate receptors. Nature 388, 179-182.
226. Vignes, M., Bleakman, D., Lodge, D., Collingridge, G.L., 1997. The synaptic activation of the GluR5 subtype of kainate receptor in area CA3 of the rat hippocampus. Neuropharmacology 36, 1477-1481.
227. Vizi, E.S., Mike, A., Tarnawa, I., 1996. 2,3-Benzodiazepines (GYKI52466 and analogs): Negative allosteric modulators of AMPA receptors. CNS Drug Rev. 2, 91-126.
228. Vyklicky, L. Jr., Patneau, D.K., Mayer, M.L., 1991. Modulation of excitatory synaptic transmission by drugs that reduce desensitization at AMPA/kainate receptors. Neuron 7, 971-984.
229. Watkins, J.C., Evans, R.H., 1981. Excitatory amino acid transmitters. Annu. Rev. Pharmacol. Toxicol. 21, 165-204.
230. Wenthold, R.J., Petralia, R.S., Blahos, J. II, Niedzielski, A.S., 1996. Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J. Neurosci. 16, 1982-1989.
231. Werner, P., Voigt, M., Keinänen, K., Wisden, W., Seeburg, P.H., 1991. Cloning of a putative high affinity kainate receptor expressed predominantly in hippocampal CA3 cells. Nature 351, 742-744.
232. Westbrook, G.L., Lothman, E.W., 1983. Cellular and synaptic basis of kainic acid-induced hippocampal epileptiform activity. Brain Res. 273, 97-109.
233. Wilding, T.J., Huettner, J.E., 1995. Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines. Mol. Pharmacol. 47, 582-587.
234. Wilding, T.J., Huettner, J.E., 1996. Antagonist pharmacology of kainate and alpha amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid preferring receptors. Mol. Pharmacol. 49, 540-546.
235. Wilding, T.J., Huettner, J.E., 1997. Activation and desensitization of hippocampal kainate receptors. J. Neurosci. 17, 2713-2721.
236. Williams, K., 1997. Interactions of polyamines with ion channels. Biochem. J. 325, 289-297.
237. Willis, C.L., Meldrum, B.S., Nunn, P.B., Anderton, B.H., Leigh, P.N., 1993. Neuronal damage induced by β-N-oxalylamino-L-alanine in the rat hippocampus can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. Brain Res. 627, 55-62.
238. Wisden, W., Seeberg, P.H., 1993. A complex mosaic of high affinity kainate receptors in rat brain. J. Neurosci. 13, 3582-3598.
239. Wo, Z.G., Oswald, R.E., 1994. Transmembrane topology of two kainate receptor subunits revealed by N-glycosylation. Proc. Natl. Acad. Sci. USA 91, 7154-7158.
240. Wong, L.A., Mayer, M.L., Jane, D.E., Watkins, J.C., 1994. Willardiines differentiate agonist binding sites for kainate-versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons. J. Neurosci. 14, 3881-3897.
241. Wroblewski, J.T., Danysz, W., 1989. Modulation of glutamate receptors: Molecular mechanisms and functional implications. Annu. Rev. Pharmacol. Toxicol. 29, 441-474.
242. Xue, D., Huang, Z.-G., Barnes, K., Lesiuk, H.J., Smith, K.E., Buchan, A.M., 1994. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. J. Cereb. Blood Flow Metab. 14, 251-261.
243. Yamaguchi, S., Donevan, S.D., Rogawski, M.A., 1993. Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI52466 and NBQX in maximal electroshock and chemoconvulsant seizure models. Epilepsy Res. 15, 179-184.
244. Yao, H., Ibayashi, S., Nakane, H., Cai, H., Uchimura, H., Fujishima, M., 1997. AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats. Brain Res. 753, 80-85.
245. Yatsugi, S., Takahashi, M., Kawasaki-Yatsugi, S., Koshiya, K., Sakamoto, S., Uematsu, D., Shimizu-Sasamata, M., 1996. Neuroprotective effects of YM90K, a novel AMPA/kainate receptor antagonist, in focal cerebral ischemia in the cats. J. Cereb. Blood Flow Metab. 16, 959-966.
246. Zeman, S., Lloyd, C., Meldrum, B.S., Leigh, P.N., 1994. Excitatory amino acids, free radicals and the pathogenesis of motoneuron disease. Neuropathol. Appl. Neurobiol. 20, 219-231.
247. Zhou, L.-M., Gu, Z.-Q., Costa, A.M., Yamada, K.A., Mansson, P.E., Giordano, T., Skolnick, P., Jones, K.A., 1997. (2S,4R)-4-methylglutamic acid (SYM 2081): A selective, high affinity ligand for kainate receptors. J. Pharmacol. Exp. Ther. 280, 422-427.
248. Zieglgansberger, W., Puil, B.A., 1973. Actions of glutamic acid on spinal neurons. Exp. Brain Res. 17, 35-49.
249. Zivkovic, I., Thompson, D.M., Bertolino, M., Uzunov, D., DiBella, M., Costa, E., Guidotti, A., 1995. 7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazole-propanoic acid (AMPA) receptor desensitization. J. Pharmacol. Exp. Ther. 272, 300-309.
250. Zorumski, C.F., Thio, L.L., 1992. Properties of vertebrate glutamate receptor: Calcium mobilization and desensitization. Prog. Neurobiol. 39, 295-336.
251. Zorumski, C.F., Thio, L.L., Clifford, D.B., 1991. Effects of bromowillardiine and willardiine on non-N-methyl-D-aspartate receptors in postnatal rat hippocampal neurons. Mol. Pharmacol. 40, 45-51.
252. Zorumski, C.F., Yamada, K.A., Price, M.T., Olney, J.W., 1993. A benzodiazepine recognition site associated with the non-NMDA glutamate receptor. Neuron 10, 61-67.